Maryann N. Krasko
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Maryann N. Krasko has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Michelle Renee Ciucci
Department of Otolaryngology‐Head and Neck Surgery, Communication Sciences and Disorders University of Wisconsin‐Madison Madison Wisconsin USA
6 shared publications - Denis Michael Rudisch
Department of Communication Sciences and Disorders, University of Wisconsin-Madison, Madison, WI, United States
3 shared publications - Nicole E. Schaen-Heacock
Department of Communication Sciences and Disorders University of Wisconsin‐Madison Madison Wisconsin USA
3 shared publications - Alex F. Nisbet
Division of Human Genetics Children's Hospital of Philadelphia Philadelphia Pennsylvania USA
2 shared publications - Courtney K. Broadfoot
Department of Medicine, Division of Geriatrics and Gerontology, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, USA
2 shared publications - Cynthia A. Kelm-Nelson
Department of Surgery, Division of Otolaryngology, University of Wisconsin-Madison, Madison, WI, United States
2 shared publications
Latest Publications
- Open Access
- 28 July 2026
- Published by Springer Nature in Dysphagia
- p. 1-10
Pressure and Timing Differences Between Volitional and Non-Cued Saliva Swallows Measured with Pharyngeal High-Resolution Manometry
Volitional and spontaneous swallowing occur regularly throughout the day, yet most research has primarily focused on cued volitional swallowing. Differences in sensory input and degree of cortical involvement between swallow types may contribute to differences in swallowing physiology. Pharyngeal high-resolution manometry provides an opportunity to characterize both swallow types. Pressure generation and timing events during cued volitional (2 cc thin liquid) and non-cued saliva swallowing were evaluated in 50 healthy adults (n = 25 per sex). Paired t-tests revealed that on average, significantly greater pressures were generated during volitional swallows than non-cued saliva swallows in the velopharynx ( p < 0.0001), tongue base ( p = 0.045), and UES (post-closure) regions ( p = 0.0058), while no significant differences were noted in the hypopharynx ( p > 0.05). Positive linear relationships between swallow types were identified for velopharyngeal and tongue base pressures. Additionally, volitional swallows demonstrated longer UES relaxation durations than non-cued saliva swallows ( p = 0.0003). While C2-C4 size differed between males (larger) and females ( p < 0.0001), sex was not associated with any swallowing outcome measures. Overall, healthy adults generated higher pressures during volitional than non-cued saliva swallows in most pharyngeal regions, whereas the hypopharynx appeared less influenced by swallow type. Positive relationships between swallow types suggest that volitional assessments can serve as useful proxies for spontaneous function and may provide clinically relevant information when standard bolus swallows are difficult to obtain. The absence of sex effects supports uniform interpretation of manometric results across adults. These results underscore the importance of considering swallow type when evaluating swallowing physiology and designing clinical interventions.
- 28 July 2026
- Published by Springer Nature in Dysphagia
- p. 1-10
Open AccessPressure and Timing Differences Between Volitional and Non-Cued Saliva Swallows Measured with Pharyngeal High-Resolution Manometry
Volitional and spontaneous swallowing occur regularly throughout the day, yet most research has primarily focused on cued volitional swallowing. Differences in sensory input and degree of cortical involvement between swallow types may contribute to differences in swallowing physiology. Pharyngeal high-resolution manometry provides an opportunity to characterize both swallow types. Pressure generation and timing events during cued volitional (2 cc thin liquid) and non-cued saliva swallowing were evaluated in 50 healthy adults (n = 25 per sex). Paired t-tests revealed that on average, significantly greater pressures were generated during volitional swallows than non-cued saliva swallows in the velopharynx ( p < 0.0001), tongue base ( p = 0.045), and UES (post-closure) regions ( p = 0.0058), while no significant differences were noted in the hypopharynx ( p > 0.05). Positive linear relationships between swallow types were identified for velopharyngeal and tongue base pressures. Additionally, volitional swallows demonstrated longer UES relaxation durations than non-cued saliva swallows ( p = 0.0003). While C2-C4 size differed between males (larger) and females ( p < 0.0001), sex was not associated with any swallowing outcome measures. Overall, healthy adults generated higher pressures during volitional than non-cued saliva swallows in most pharyngeal regions, whereas the hypopharynx appeared less influenced by swallow type. Positive relationships between swallow types suggest that volitional assessments can serve as useful proxies for spontaneous function and may provide clinically relevant information when standard bolus swallows are difficult to obtain. The absence of sex effects supports uniform interpretation of manometric results across adults. These results underscore the importance of considering swallow type when evaluating swallowing physiology and designing clinical interventions.
- 27 April 2024
- Published by Elsevier in Brain Research
- Vol. 1837, 148958
Vocal and tongue exercise in early to mid-stage Parkinson disease using the Pink1-/- rat
- 27 April 2024
- Published by Elsevier in Brain Research
- Vol. 1837, 148958
Vocal and tongue exercise in early to mid-stage Parkinson disease using the Pink1-/- rat
- 24 April 2023
- Published by Springer Nature in Current Physical Medicine and Rehabilitation Reports
- Vol. 11 (2) , 188-198
Dysphagia in Parkinson Disease: Part II—Current Treatment Options and Insights from Animal Research
Purpose of Review Dysphagia is highly prevalent in Parkinson disease (PD) but is not typically identified nor treated until later in the disease process. This review summarizes current pharmacological, surgical, and behavioral treatments for PD-associated dysphagia and contributions from translational animal research. Recent Findings Swallowing is a complex physiologic process controlled by multiple brain regions and neurotransmitter systems. As such, interventions that target nigrostriatal dopamine dysfunction have limited or detrimental effects on swallowing outcomes. Behavioral interventions can help target PD-associated dysphagia in mid-to-late stages. Animal research is necessary to refine treatments and useful in studying prodromal dysphagia. Summary Dysphagia is an early, common, and debilitating sign of PD. Current pharmacological and surgical interventions are not effective in ameliorating swallowing dysfunction; behavioral intervention remains the most effective approach for dysphagia treatment. Animal research has advanced our understanding of mechanisms underlying PD and PD-associated dysphagia, and continues to show translational promise for the study of dysphagia treatment options.
- 24 April 2023
- Published by Springer Nature in Current Physical Medicine and Rehabilitation Reports
- Vol. 11 (2) , 188-198
Dysphagia in Parkinson Disease: Part II—Current Treatment Options and Insights from Animal Research
Purpose of Review Dysphagia is highly prevalent in Parkinson disease (PD) but is not typically identified nor treated until later in the disease process. This review summarizes current pharmacological, surgical, and behavioral treatments for PD-associated dysphagia and contributions from translational animal research. Recent Findings Swallowing is a complex physiologic process controlled by multiple brain regions and neurotransmitter systems. As such, interventions that target nigrostriatal dopamine dysfunction have limited or detrimental effects on swallowing outcomes. Behavioral interventions can help target PD-associated dysphagia in mid-to-late stages. Animal research is necessary to refine treatments and useful in studying prodromal dysphagia. Summary Dysphagia is an early, common, and debilitating sign of PD. Current pharmacological and surgical interventions are not effective in ameliorating swallowing dysfunction; behavioral intervention remains the most effective approach for dysphagia treatment. Animal research has advanced our understanding of mechanisms underlying PD and PD-associated dysphagia, and continues to show translational promise for the study of dysphagia treatment options.
- 28 March 2023
- Published by Springer Nature in Current Physical Medicine and Rehabilitation Reports
- Vol. 11 (2) , 176-187
Dysphagia in Parkinson Disease: Part I – Pathophysiology and Diagnostic Practices
Purpose of Review Dysphagia affects the majority of individuals with Parkinson disease (PD) and is not typically diagnosed until later in disease progression. This review will cover the current understanding of PD pathophysiology, and provides an overview of dysphagia in PD including diagnostic practices, gaps in knowledge, and future directions. Recent Findings Many non-motor and other motor signs of PD appear in the prodrome prior to the manifestation of hallmark signs and diagnosis. While dysphagia often presents already in the prodrome, it is not routinely addressed in standard neurology examinations. Summary Dysphagia in PD can result in compromised efficiency and safety of swallowing, which significantly contributes to malnutrition and dehydration, decrease quality of life, and increase mortality. The heterogeneous clinical presentation of PD complicates diagnostic procedures which often leads to delayed treatment. Research has advanced our knowledge of mechanisms underlying PD, but dysphagia is still largely understudied, especially in the prodromal stage.
- 28 March 2023
- Published by Springer Nature in Current Physical Medicine and Rehabilitation Reports
- Vol. 11 (2) , 176-187
Dysphagia in Parkinson Disease: Part I – Pathophysiology and Diagnostic Practices
Purpose of Review Dysphagia affects the majority of individuals with Parkinson disease (PD) and is not typically diagnosed until later in disease progression. This review will cover the current understanding of PD pathophysiology, and provides an overview of dysphagia in PD including diagnostic practices, gaps in knowledge, and future directions. Recent Findings Many non-motor and other motor signs of PD appear in the prodrome prior to the manifestation of hallmark signs and diagnosis. While dysphagia often presents already in the prodrome, it is not routinely addressed in standard neurology examinations. Summary Dysphagia in PD can result in compromised efficiency and safety of swallowing, which significantly contributes to malnutrition and dehydration, decrease quality of life, and increase mortality. The heterogeneous clinical presentation of PD complicates diagnostic procedures which often leads to delayed treatment. Research has advanced our knowledge of mechanisms underlying PD, but dysphagia is still largely understudied, especially in the prodromal stage.
- 22 March 2023
- Published by Springer Nature in Dysphagia
- Vol. 38 (5) , 1382-1397
Pink1-/- Rats Demonstrate Swallowing and Gastrointestinal Dysfunction in a Model of Prodromal Parkinson Disease
Early motor and non-motor signs of Parkinson disease (PD) include dysphagia, gastrointestinal dysmotility, and constipation. However, because these often manifest prior to formal diagnosis, the study of PD-related swallow and GI dysfunction in early stages is difficult. To overcome this limitation, we used the Pink1-/- rat, a well-established early-onset genetic rat model of PD to assay swallowing and GI motility deficits. Thirty male rats were tested at 4 months (Pink1-/- = 15, wildtype (WT) control = 15) and 6 months (Pink1-/- = 7, WT = 6) of age; analogous to early-stage PD in humans. Videofluoroscopy of rats ingesting a peanut-butter-barium mixture was used to measure mastication rate and oropharyngeal and pharyngoesophageal bolus speeds. Abnormal swallowing behaviors were also quantified. A second experiment tracked barium contents through the stomach, small intestine, caecum, and colon at hours 0–6 post-barium gavage. Number and weight of fecal emissions over 24 h were also collected. Compared to WTs, Pink1-/- rats showed slower mastication rates, slower pharyngoesophageal bolus speeds, and more abnormal swallowing behaviors. Pink1-/- rats demonstrated significantly delayed motility through the caecum and colon. Pink1-/- rats also had significantly lower fecal pellet count and higher fecal pellet weight after 24 h at 6 months of age. Results demonstrate that swallowing dysfunction occurs early in Pink1-/- rats. Delayed transit to the colon and constipation-like signs are also evident in this model. The presence of these early swallowing and GI deficits in Pink1-/- rats are analogous to those observed in human PD.
- 22 March 2023
- Published by Springer Nature in Dysphagia
- Vol. 38 (5) , 1382-1397
Pink1-/- Rats Demonstrate Swallowing and Gastrointestinal Dysfunction in a Model of Prodromal Parkinson Disease
Early motor and non-motor signs of Parkinson disease (PD) include dysphagia, gastrointestinal dysmotility, and constipation. However, because these often manifest prior to formal diagnosis, the study of PD-related swallow and GI dysfunction in early stages is difficult. To overcome this limitation, we used the Pink1-/- rat, a well-established early-onset genetic rat model of PD to assay swallowing and GI motility deficits. Thirty male rats were tested at 4 months (Pink1-/- = 15, wildtype (WT) control = 15) and 6 months (Pink1-/- = 7, WT = 6) of age; analogous to early-stage PD in humans. Videofluoroscopy of rats ingesting a peanut-butter-barium mixture was used to measure mastication rate and oropharyngeal and pharyngoesophageal bolus speeds. Abnormal swallowing behaviors were also quantified. A second experiment tracked barium contents through the stomach, small intestine, caecum, and colon at hours 0–6 post-barium gavage. Number and weight of fecal emissions over 24 h were also collected. Compared to WTs, Pink1-/- rats showed slower mastication rates, slower pharyngoesophageal bolus speeds, and more abnormal swallowing behaviors. Pink1-/- rats demonstrated significantly delayed motility through the caecum and colon. Pink1-/- rats also had significantly lower fecal pellet count and higher fecal pellet weight after 24 h at 6 months of age. Results demonstrate that swallowing dysfunction occurs early in Pink1-/- rats. Delayed transit to the colon and constipation-like signs are also evident in this model. The presence of these early swallowing and GI deficits in Pink1-/- rats are analogous to those observed in human PD.
- 22 April 2022
- Published by Elsevier in Brain Research Bulletin
- Vol. 185, 49-55
Assays of tongue force, timing, and dynamics in rat and mouse models
- 22 April 2022
- Published by Elsevier in Brain Research Bulletin
- Vol. 185, 49-55
Assays of tongue force, timing, and dynamics in rat and mouse models
- Open Access
- 13 July 2021
- Published by MDPI AG in Brain Sciences
- Vol. 11 (7) , 925
Rat Models of Vocal Deficits in Parkinson’s Disease
Parkinson’s disease (PD) is a progressive, degenerative disorder that affects 10 million people worldwide. More than 90% of individuals with PD develop hypokinetic dysarthria, a motor speech disorder that impairs vocal communication and quality of life. Despite the prevalence of vocal deficits in this population, very little is known about the pathological mechanisms underlying this aspect of disease. As such, effective treatment options are limited. Rat models have provided unique insights into the disease-specific mechanisms of vocal deficits in PD. This review summarizes recent studies investigating vocal deficits in 6-hydroxydopamine (6-OHDA), alpha-synuclein overexpression, DJ1-/-, and Pink1-/- rat models of PD. Model-specific changes to rat ultrasonic vocalization (USV), and the effects of exercise and pharmacologic interventions on USV production in these models are discussed.
- 13 July 2021
- Published by MDPI AG in Brain Sciences
- Vol. 11 (7) , 925
Open AccessRat Models of Vocal Deficits in Parkinson’s Disease
Parkinson’s disease (PD) is a progressive, degenerative disorder that affects 10 million people worldwide. More than 90% of individuals with PD develop hypokinetic dysarthria, a motor speech disorder that impairs vocal communication and quality of life. Despite the prevalence of vocal deficits in this population, very little is known about the pathological mechanisms underlying this aspect of disease. As such, effective treatment options are limited. Rat models have provided unique insights into the disease-specific mechanisms of vocal deficits in PD. This review summarizes recent studies investigating vocal deficits in 6-hydroxydopamine (6-OHDA), alpha-synuclein overexpression, DJ1-/-, and Pink1-/- rat models of PD. Model-specific changes to rat ultrasonic vocalization (USV), and the effects of exercise and pharmacologic interventions on USV production in these models are discussed.